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Oxidative phosphorylation within mitochondria is the main source of aerobic energy for neu-
ronal functioning, and the key genes are located in mitochondrial DNA. Deficits in oxidative
phosphorylation functioning have been reported for schizophrenia, but efforts in the identifi-
cation of genetic markers within the mitochondrial DNA that predispose to schizophrenia
have been limited. We genotyped a set of mitochondrial SNPs using Illumina HumanExome
arrays and tested for association in the Swedish schizophrenia sample (N> 10,000). We
developed a novel approach for mitochondrial DNA imputation in order to increase the num-
ber of common SNPs available for association analysis. The most significant findings were
for the mitochondrial SNPs C15452A (GRCh38.p10; rs527236209; p = 0.007; gene MT-
CYB; defining haplogroup JT); A11251G (rs869096886; p = 0.007; gene MT-ND4; defining
haplogroup JT), and T4216C (rs1599988; p = 0.008, gene MT-ND1, defining haplogroup
R2’JT). We also conducted rare variant burden analyses and obtained a p-value of 0.007.
For multimarker haplotypes analysis, the most significant finding was for the J group (OR:
0.86, p = 0.02). We conducted the largest association study of mitochondrial DNA variants
and schizophrenia but did not find an association that survived multiple testing correction.
Analysis of a larger sample is required and will allow a better understanding of the role of
mitochondria in schizophrenia.
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Introduction
Schizophrenia (SCZ) is a complex disorder characterized by psychosis and disturbed behavior.
The heritability of SCZ is estimated at 80% [1] and although substantial progress has been
made [1,2], the genetic risk factors are still far from being fully understood.
Oxidative phosphorylation within mitochondria is the main source of aerobic energy for
neuronal functioning. Genes within the pathway are encoded by the nuclear genome (approxi-
mately 95 genes) as well as by mitochondrial DNA (13 genes). Impairments in oxidative phos-
phorylation might be involved in the pathophysiology of diseases with bioenergetic deficits.
Deficits in brain energy metabolism have been noted in SCZ, and mitochondrial dysfunction
in SCZ has been proposed (reviewed by Gonçalves et al. [3]).
Genetic evidence has suggested that nuclear-encoded mitochondrial genes may play a role in
SCZ [1], although the mitochondrial related pathways were not significantly associated with the
disease in a recent large study (N = 9,379 SCZ cases) [4]. There are a limited number of association
studies between mitochondrial DNA and schizophrenia, and the results have been conflicting [3].
Some studies focused on the association of mtDNA haplogroups (i.e., clusters of mitochondrial
sequences sharing a specific set of polymorphisms as consequence of having a common ancestor).
Positive findings were reported between haplogroup HV and SCZ in an Israeli sample (N = 220
cases) [5]; and between haplogroup J-T and onset of SCZ in an Italian sample (N = 142 cases) [6].
Hudson et al [7] found nominally significant associations between SCZ and SNPs defining hap-
logroup U in a data set based on genotyped and imputed SNPs (N = 2,950 cases). Positive findings
were also reported on non-Europeans, for example, a study in Han Chinese population showed an
association between haplogroup B5a and SCZ risk in a sample size of 1,212 cases [8]. Wang et al.
[9] analyzed haplogroups and control region sequence data in a Chinese Han population and they
reported a nominal association between haplogroup N9a and SCZ (N = 298 cases).
However, more recent studies do not support these findings [10–13], although the approaches
used to assign individuals into haplogroups varied across the studies. For example, Bertolin et al.
[11] conducted a case–control study in very small Italian SCZ and bipolar sample (N = 89 cases),
and did not observe a difference in haplogroup frequencies between cases and controls. Mos-
quera-Miguel [12] genotyped 16 tag SNPs in two Spanish sample, and reported no association
between major European haplogroups and SCZ (N = 942). Torrel et al [13] also reported negative
findings for haplogroups HV, JT and U in a Spanish population (N = 495 cases). For non-Europe-
ans, Ueno et al. [10] analyzed sequences of 93 SCZ Japanese subjects and compared frequencies of
haplogroups with healthy controls. They did not find a significant difference between the two
groups. Xu et al [14] performed restriction fragment length polymorphism PCR (PCR-RFLP)
using four mtDNA SNPs in the coding region as well as sequencing of the control region to ana-
lyze haplogroups and variants in a Han Chinese case-control sample (313 cases). They did not
find any significant association between variants or haplogroups and SCZ risk.
Two studies, the largest to date, with approximately 3,000 cases each and partially overlap-
ping samples [7,15], investigated SNPs and found nominal associations. A study in Han Chi-
nese families reported the presence of private non-synonymous variants in probands with SCZ
[16]. Here, we tested the hypothesis that mitochondrial DNA variants play a role in SCZ. To
the best of our knowledge, this is the largest study of its type.
Methods
Genotyping quality control
A comprehensive set of 220 mitochondrial SNPs were genotyped in one batch using Illumina
HumanExome arrays and tested for association in a previously described Swedish SCZ case-
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control sample (N = 10,771) [2]. Samples that passed autosomal quality control procedures
were selected (N = 4778 cases and N = 5819 controls) [17]. Additional quality control steps
comprised removing individuals showing missing genotype rate greater than 5% for mito-
chondrial markers (N = 3). A total of 729 heterozygous haplotypes possibly due to mitochon-
drial heteroplasmy were coded as missing (final N = 4775 cases and N = 5819 controls).
Genotype data were available for 42 coding region SNPs with a minor allele frequency (MAF)
greater than 1% and 123 coding region SNPs with MAF 1%. We excluded SNPs in the con-
trol region (16024 to 576 bp) because there are no genes in this region (Information regarding
the genotypes for common SNPs are described in the S1 Table).
Haplogroup assignment
We used HaploGrep [18] to assign haplotypes to haplogroups and to check for potential con-
tamination in our dataset. Briefly, HaploGrep weights each polymorphism present in Phylo-
tree17 (a phylogenetic tree of worldwide human mitochondrial DNA variation) based on its
informativeness to define haplogroups. The set of SNPs in the input file are classified as infor-
mative or remaining (not informative). A score is given based on the weights of the “informa-
tive SNPs” but it is “penalized” by the number of remaining SNPs (for details see (14)). There
are eight main Europeans haplogroups under the N clade: HV (H, V), JT (J, T), U (which
includes K), I, W, and X [19]. To check for contamination or uncertainty in the haplogroup
classification (the last due to limited number of SNPs available in the genotyping chip), we
attempted to assign haplogroups with the remaining SNPs. In clean data, the reference group
H2a2a1 is expected, but if a different haplogroup is assigned, it suggests contamination.
We found a second haplogroup for 3.5% of the sample and we excluded these individuals
(N = 380) from further analysis. Thus, the total number of samples available for analysis was
10,214 (4,591 cases and 5,623 controls). We also excluded samples with imputed haplogroups
with overall rank less than 0.8.
Mitochondrial DNA imputation approach
We developed a novel approach for mitochondrial DNA imputation that allowed us to gain
data for another 30 common SNPs giving us 71 in total (considering post-imputation filters of
“info” score > 0.3 and MAF > 1%). We downloaded 7,141 public European mitochondrial
sequences from Human Mitochondrial DataBase [20] and used them as reference panel (SNP
N = 188 after filtered by MAF > 1%). Imputation was performed using IMPUTE2 v.2 software
[21], following the instructions for chromosome X and recoding all individuals in Swedish
data set as males for the purpose of this analysis (List of haplotypes with genotyped/imputed
SNPs are in S3 Table). We evaluated imputation performance, both by removing genotyped
SNPs one at a time from input files and confirming accuracy of imputed genotypes and by
comparing allele frequencies of the imputed SNPs with reported frequencies from other data-
sets (see Results section).
To determine the accuracy of our approach to assign haplogroups based on genotypes and
to check whether imputed data would more accurately identify haplogroups than genotyped-
only SNPs (from the Illumina HumaExome array), we performed the following analysis: i) We
determined which haplogroups were present in our data using HaploGrep2; ii) We then
extracted the full profile for each of these from Phylotree17; iii) From these profiles we selected
only SNPs present on the Illumina HumanExome array to create pseudo-samples; and iv) We
then imputed back any missing data for these pseudo-samples. Then, we compared the Phylo-
tree assigned haplogroup with the haplogroups defined based on imputed (genotyped/imputed
SNPs) and genotyped-only SNPs.
Mitochondrial DNA variants in schizophrenia
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Statistical analysis
For single marker tests, associations with SCZ for the 71 common SNPs (genotyped and
imputed) were tested using SNPTEST v2.8 with the frequentist test and expected method. We
conducted rare variants analyses on the genotyped markers with sequence Kernel association
test (SKAT) [22], using Davies method to compute the p-value (an exact method that com-
putes the p-value by inverting the characteristic function of the mixture chi square distribu-
tions) and using weights from a beta function on the MAF (SKAT default weights).
Following haplogroup assignment, we performed multidimensional scaling analysis (MDS)
and plotted the first two dimensions in order to visualize traditional mtDNA haplogroups.
Association testing was performed using macro-haplogroups, in which some phylogenetically-
related haplogroups were combined. We tested the association between the macro-hap-
logroups HV, J, T, and U and SCZ using logistic regression. Power calculation was performed
using Quanto 1.2.4 [23].
Results
A total of 194 SNPs were present in the imputation output of which 41 had been genotyped
(one SNP was filtered out due to excessive missing data after removal of 381 individuals with
uncertain haplogroup assignment) and 153 imputed (141 in the coding region). After filtering
for info score 0.3 and MAF 1%, we retained 71 SNPs (41 genotyped and 30 imputed) in
the coding region for univariate association analysis. The 71 SNPs available for analysis
equated to 35 independent tests (determined using SNP Spectral Decomposition Lite) [24].
We applied a Bonferroni-corrected significance threshold of 0.001. For MAF 1%, this sam-
ple had 80% power to detect a genotype relative risk of 1.6 (additive model, α = 0.001). Power
for genome-wide significance (α = 5x10-8) was lower (80% power for a relative risk of 2.0).
To validate our mtDNA imputation approach, we removed the genotyped SNPs one at a
time from input files and we were able to impute 34 of them (total number was 41). Our
approach was efficient with 96% accuracy (S1 Fig). Furthermore, comparative analysis showed
similar allele frequencies between imputed and genotyped SNPs from our study with the
Swedish data described by Saxena et al [25] (N = 1,010) (S2 Fig).
In order to check the accuracy of genotype-only (array) and genotype/imputed SNPs to
assign to haplogroups, we compared the results using both approaches with the expected hap-
logroup based on Phylotree17. We observed 90% concordance between Phylotree expected
haplogroup and haplogroup assigned by genotyped-only SNPs (array) versus 86% concor-
dance with results from genotyped/imputed SNPs.
For single SNP analysis, the most significant findings were for SNPs C15452A (rs527236209;
p = 0.007, gene MT-CYB), A11251G (rs869096886; p = 0.007; gene MT-ND4), and T4216C
(rs1599988; p = 0.008; gene MT-ND1) (Table 1). All three SNPs are used the define haplogroup
JT. We also conducted rare variants analyses on the genotyped markers (N = 123 SNPs,
MAF 1%) using SKAT [22] and obtained a p-value of 0.007.
For analyses of haplogroup, we were able to assign most samples reliably into four Euro-
pean macro-haplogroups, HV, J, T, and U (Fig 1). Individuals assigned to the remaining Euro-
pean mtDNA haplogroups as well as non-European haplogroups were not included in our
analysis. The most significant finding was for the J group (p = 0.02; 8.3% in cases and 9.7% in
controls; OR: 0.86) (Table 2). The haplogroups identified in this study were listed in S2 Table.
Discussion
In this study, we conducted the largest study to date investigating the role of mtDNA SNPs in
the susceptibility to SCZ. None of the associations survived correction for multiple testing.
Mitochondrial DNA variants in schizophrenia
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However, we validated an imputation method for mitochondrial DNA that should improve
our ability to identify associations in studies with more SNPs and/or samples.
We started with the set of 41 common genotyped SNPs and were initially only able to iden-
tify two (H and T) of the eight expected haplogroups (S3 Fig). The other groups were seen as
one overlapped group, after the multidimensional scaling analysis. It was suggestive that
important SNPs were missing for an accurate group analysis, and thus, we decided to impute
Table 1. Top association for single SNPs association analysis results.
SNP rs_number
(GRCH38.p10)





rs527236209 NC_012920.1:m.15452C>A 15452 A 7.2 9.9 0.86
(0.80 0.93)
0.007
rs869096886 no available 11251 G 7.2 9.9 0.86
(0.80 0.93)
0.007
rs1599988 NC_012920.1:m.4216T>C 4216 C 7.4 10.1 0.86
(0.80 0.93)
0.008
 Frequency in %.
https://doi.org/10.1371/journal.pone.0191153.t001
Fig 1. mtDNA genetic grouping. Colors correspond to the traditional mtDNA haplogroups according to HaploGrep2.
The four clear groups defined by first and second dimensions are highlighted.
https://doi.org/10.1371/journal.pone.0191153.g001
Mitochondrial DNA variants in schizophrenia
PLOS ONE | https://doi.org/10.1371/journal.pone.0191153 January 25, 2018 5 / 9
mtDNA. We used standard approaches for imputation but adjusting for the unique features of
mtDNA (such as the use of chromosome X protocol and removal of heterozygous genotypes).
Using imputed mtDNA data, we were able to identify more clusters representing the hap-
logroups J, T, HV, and U. In future, haplogroup classification using microarrays could be
improved by designing arrays that contain SNPs that are informative in relation to phylogeny.
Noteworthy, in our current approach, we did not exclude hotspot variants from the imputed
data before performing statistical analysis or haplogroup assignments. However, in our
imputed data, we found only two hotspot variants (MT:5147 and MT:8251), as defined by
Soares et al [26]. These variants have medium (4.6 and 4.5) HaploGrep2 weights respectively
according to Weißensteiner et al [27] (the weight indicates the importance of the variant in the
haplogroup assignment; lower values mean less influence on the classification by the tool—
scale from 1-to-10). Thus, they do not have a strong influence on the haplogroup assignment.
The strongest findings for the single SNP analysis were for the SNPs C15452A
(rs527236209); p = 0.007 (gene MT-CYB); A11251G (rs869096886); p = 0.007 (gene MT-ND4),
and T4216C (rs1599988); p = 0.008 (gene MT-ND1). The three SNPs are used to define hap-
logroup J. We also found that the haplogroup J was the most strongly associated with SCZ.
This SNP C15452A (rs193302994) is a non-synonymous variant located in the Cytochrome
b gene, which is the largest subunit of the oxidative phosphorylation complex III. The SNP
A11251G (rs869096886) is a synonymous variant (syn L:L) located in the MT-ND4 gene
(Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 4). Both SNPs
define the haplogroup JT and its subclades (i.e., J and T haplogroups and their sub-hap-
logroups). The haplogroup JT was associated with age at onset in very small SCZ sample [6]
but it was negative in two studies testing the association of mitochondrial haplogroups with
SCZ [12,13]. The SNP T4216C (rs1599988) is a non-synonymous variant located in the
MT-ND1 (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1). This
SNP is key to define the pre-JT haplogroup and its subclades.
In conclusion, we did not find a significant association between mtDNA SNPs or hap-
logroups and SCZ. Variants with large effects are not expected to be found in the mitochon-
drial DNA due to fact that those variants (deleterious) are eliminated by the ovarian selection
system [28]. Therefore, even a sample of>10,000 may not be adequately large to detect mito-
chondrial genetic variants that are associated with SCZ. Furthermore, a deeper analysis of rare
mtDNA variants, particularly in larger samples, will shed light on the role of mitochondria in
SCZ.
We were able to develop an imputation approach for mitochondrial DNA that will allow us
to comprehensively analyze mitochondrial SNPs from groups such as the Psychiatric Geno-
mics Consortium. Our study has some limitations: i) inability to assign people into all the hap-
logroups; however, assignment should be improved by increasing the current reference panel
size for mitochondrial DNA imputation; ii) Our imputation approach does not outperform
the haplogroup assignment by the genotyped-only SNPs (Illumina HumanExome array).
Analysis of a larger sample is required and will allow a better understanding of the role of
mitochondria in SCZ.
Table 2. Top hits from mtDNA macro-haplogroup association analysis.
Haplogroups % Controls %Cases p-value OR (CI)
J 9.7 8.3 0.02 0.86 (0.74–0.98)
H-HV-V 49.5 50.3 0.48 1.03 (0.95–1.11)
T 8.7 7.9 0.16 0.90 (0.78–1.04)
U(K) 25.1 25.9 0.37 1.04 (.095–1.14)
https://doi.org/10.1371/journal.pone.0191153.t002
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Supporting information
S1 Fig. Imputation accuracy. The axis Y shows concordance percentages between genotyped
and imputed data sets for each of SNP present in the Illumina HumanExome arrays (coding
region).
(TIF)
S2 Fig. Comparison of imputed SNPs frequencies between our study and Saxena et al[25].
(TIF)
S3 Fig. mtDNA genetic grouping using genotyped data only. Colors correspond to the tradi-
tional mtDNA haplogroups according to HaploGrep2. The three clear groups defined by first
and second dimensions are highlighted.
(TIFF)
S1 Table. Information regarding the genotypes for common SNPs present in the Illumina
HumanExome arrays.
(XLS)
S2 Table. Haplogroups identified in this study using imputed mtDNA data.
(XLSX)
S3 Table. List of haplotypes (genotyped/imputed SNPs) found in this study.
(XLS)
Acknowledgments
We would like to acknowledge Benjamin Neale who performed the first pass data quality con-
trol on the genotypes from exome array. We also would like to acknowledge Nigel Delaney for
your inputs and help in this study. Finally, we are thankful to Hansi Weißensteiner for his
helpful support in the revision of the manuscript.
Author Contributions
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